Mycosis fungoides immunohistochemistry: what should I know?

Mycosis fungoides is a type of cutaneous T-cell lymphoma that can resemble eczema, psoriasis, or other rashes, especially early on. Immunohistochemistry applies selected antibodies to a skin sample so the pathologist can identify immune-cell markers and compare the pattern with the cells’ appearance. Findings may support an abnormal T-cell population, but no single marker establishes the diagnosis.

The report is interpreted with the rash’s duration, distribution, photographs, examination, blood findings when relevant, and sometimes results from more than one sample. Staining patterns can be incomplete or altered by treatment.

Ask which markers were tested and whether the pattern supports mycosis fungoides or another skin condition. Keep copies of pathology and clinic reports, and tell the dermatologist about creams, light treatment, or medicines used before the Biopsy because treatment can affect the sample. A repeat Biopsy or additional testing may be suggested if the rash changes or the first sample is not decisive. Do not stop prescribed treatment without advice.

Contact your dermatology team for rapidly spreading rash, new lumps, persistent fever, drenching night sweating, unexplained weight change, or worsening fatigue. Seek urgent care for signs of a serious skin infection, such as rapidly increasing redness, severe pain, pus, or fever with feeling very unwell. These symptoms need clinical assessment and do not confirm lymphoma.

What did the skin cells look like under the microscope? Which markers were abnormal, and how do they fit the rash pattern? Is the sample sufficient? Would another Biopsy or specialist pathology review help? What changes should prompt an earlier visit?